TABLE 2.
Perceived and verified cancer transmission risk for potentially suitable donor referrals with transmission risks estimated using TSANZ guidelines
| Verified risk | ||||||||
|---|---|---|---|---|---|---|---|---|
| Perceived risk | None | Not contraindicated | Minimal risk (<0.1%) | Low risk (0.1%–2%) | Intermediate risk (2%–10%) | High risk (>10%) | Contraindicated | Total |
| Declined for donation | ||||||||
| None | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not contraindicated | 0 | 2 | 0 | 0 | 0 | 0 | 2 | 4 |
| Minimal risk (<0.1%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Low risk (0.1%–2%) | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 4 |
| Intermediate risk (2%–10%) | 0 | 1 | 0 | 0 | 5 | 0 | 4 | 10 |
| High risk (>10%) | 0 | 6 | 0 | 0 | 0 | 6 | 5 | 17 |
| Contraindicated | 0 | 25 | 0 | 1 | 0 | 0 | 71 | 97 |
| Total | 0 | 34 | 0 | 4 | 5 | 6 | 83 | 132 |
| Actual donors | ||||||||
| None | 283 | 24 | 0 | 0 | 0 | 0 | 0 | 307 |
| Not contraindicated | 0 | 25 | 0 | 0 | 0 | 0 | 3 | 28 |
| Minimal risk (<0.1%) | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 |
| Low risk (0.1%–2%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 2 |
| Intermediate risk (2%–10%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| High risk (>10%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Contraindicated | 0 | 0 | 0 | 0 | 0 | 0 | 1a | 1 |
| Total | 283 | 51 | 0 | 1 | 0 | 0 | 5 | 340 |
aOne potential donor with a malignant melanoma (perceived and verified) was accepted for donation.
TSANZ, Transplantation Society of Australia and New Zealand.